Source:http://linkedlifedata.com/resource/pubmed/id/14579737
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
2003-10-28
|
pubmed:abstractText |
The success of recombinant protein expression/purification in Escherichia coli depends on a high-fidelity system rendering purified proteins free of confounding contaminants such as endotoxin. Here we report on the expression and purification of a cryptic plasminogen-derived domain, kringle 5, which was previously reported to specifically inhibit endothelial cell growth and, therefore, angiogenesis. Using a histidine (HIS)-tag expression and Ni(+)-NTA agarose purification system identical to previous reports, we found that our purified recombinant kringle 5 did inhibit endothelial cell growth, but this activity could not be eradicated by heat denaturing or proteolysis of kringle 5 with various proteases. This led us to suspect the presence of a contaminant in the purified samples. Quantitative endotoxin testing using a limulus amoebocyte lysate assay revealed that all samples purified by Ni(+)-NTA agarose alone harbored high concentrations of endotoxin that could not be removed by additional purification on anion exchange chromatography. Finally, when kringle 5 was rendered endotoxin-free by purification on reverse phase high-performance liquid chromatography (HPLC), there was a complete loss of endothelial cell growth inhibitory activity. These results strongly suggest that endotoxin-free recombinant kringle 5 may not possess anti-angiogenic activity and demonstrates that, especially in angiogenesis type assays, endotoxin contamination can lead to a misinterpretation of results.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0736-6205
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
724-6, 728, 730 passim
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:14579737-Animals,
pubmed-meshheading:14579737-Artifacts,
pubmed-meshheading:14579737-Cattle,
pubmed-meshheading:14579737-Cell Survival,
pubmed-meshheading:14579737-Cells, Cultured,
pubmed-meshheading:14579737-Chromatography, High Pressure Liquid,
pubmed-meshheading:14579737-Drug Contamination,
pubmed-meshheading:14579737-Endothelial Cells,
pubmed-meshheading:14579737-Endotoxins,
pubmed-meshheading:14579737-Escherichia coli,
pubmed-meshheading:14579737-Humans,
pubmed-meshheading:14579737-Kringles,
pubmed-meshheading:14579737-Plasminogen,
pubmed-meshheading:14579737-Quality Control,
pubmed-meshheading:14579737-Recombinant Proteins
|
pubmed:year |
2003
|
pubmed:articleTitle |
Removal of endotoxin by reverse phase HPLC abolishes anti-endothelial cell activity of bacterially expressed plasminogen kringle 5.
|
pubmed:affiliation |
Department of Medicine, St. Vincent's Hospital, University of Melbourne, Corner of Princes and Regent Streets, Fitzroy, Melbourne, VIC, 3065, Australia. drew@medstv.unimelb.edu.au
|
pubmed:publicationType |
Comparative Study,
Evaluation Studies,
Technical Report,
Validation Studies
|